Dr. Hussein Bitar, MD

Dr. Bitar practices at Mercy Hospital Oklahoma City in Oklahoma City, Oklahoma, part of Mercy.

Dr. Bitar's NPI, 1548525645, was assigned on July 5, 2012. Dr. Bitar holds Oklahoma license 29263.

Dr. Bitar's primary practice is Mercy Hospital Oklahoma City, at 4300 West Memorial Road, Oklahoma City, OK 73120 in Oklahoma County. The practice phone is (405) 755-1515.

Dr. Bitar's primary practice is Mercy Hospital Oklahoma City in Oklahoma City, Oklahoma, part of Mercy. Dr. Bitar is also affiliated with Mercy Hospital Ardmore. The medical group on file is Mercy Clinic Oklahoma Communities. Dmand AI also links Dr. Bitar to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bitar practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Bitar's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Bitar is licensed in Oklahoma.

CMS data shows 519 Medicare services from Dr. Bitar across 14 procedure codes in 2024, for 289 Medicare patients. Medicare paid $48,357 for them.

CMS counts 289 Medicare patients who saw Dr. Bitar in 2026. The largest group is 65 to 74, with 148 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bitar's median patient age at 61, with 56% women.

In 2026, Dr. Bitar wrote 826 Medicare Part D claims for 282 patients. 54% of them were for generic drugs. CMS names the drug for 665 of them, across 21 drugs with 11 or more claims each, at $3,420,077 in total drug cost. In 2023, CMS named 392 claims across 15 drugs.

Dr. Bitar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bitar as offering telehealth. CMS counts 104 procedures of colonoscopy by Dr. Bitar, more than 81% of the clinicians it reports for that procedure.

Dmand AI links Dr. Bitar to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Crohn Disease and Inflammatory Bowel Diseases. Open Payments lists research payments to Dr. Bitar that name 1 trial.

CMS Open Payments shows 282 general payments to Dr. Bitar from 24 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 77% of the total. Abbvie Inc. paid the most, $118,864. It also lists 1 research payment totaling $81 in 2020, naming 1 clinical trial.